Published in J Am Acad Dermatol on February 22, 2007
Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol (2009) 1.05
Dermoscopy as a technique for the early identification of foot melanoma. J Foot Ankle Res (2009) 0.97
Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res (2010) 0.95
Nail apparatus melanoma: a diagnostic opportunity. An Bras Dermatol (2013) 0.83
When all you have is a dermatoscope- start looking at the nails. Dermatol Pract Concept (2014) 0.80
Tattoo pigment interpreted as lymph node metastasis in a case of subungual melanoma. Hand (N Y) (2008) 0.79
Photoacoustic discrimination of vascular and pigmented lesions using classical and Bayesian methods. J Biomed Opt (2010) 0.79
Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma - Part I. An Bras Dermatol (2015) 0.77
Simple diagnostic tests for subungual pigmentation. Dermatol Res Pract (2010) 0.75
Conservative surgical management of in situ subungual melanoma: long-term follow-up. An Bras Dermatol (2017) 0.75
Tangential Biopsy Thickness versus Lesion Depth in Longitudinal Melanonychia: A Pilot Study. Dermatol Res Pract (2012) 0.75
Multiple habit-induced nail problems including diffuse brownish chromonychia. Ann Dermatol (2014) 0.75
Nail matrix melanoma: consecutive cases in a general practice. Dermatol Pract Concept (2012) 0.75
Dermoscopy in the Evaluation of Nail Disorders. Skin Appendage Disord (2017) 0.75
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol (2009) 8.68
Magnetic domain-wall racetrack memory. Science (2008) 8.24
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med (2014) 5.43
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature (2011) 3.53
Chiral spin torque at magnetic domain walls. Nat Nanotechnol (2013) 2.98
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol (2009) 2.94
Telemedical wound care using a new generation of mobile telephones: a feasibility study. Arch Dermatol (2005) 2.91
The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol (2008) 2.87
Dermoscopic examination of nail pigmentation. Arch Dermatol (2002) 2.83
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem (2006) 2.75
Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol (2007) 2.73
Current-controlled magnetic domain-wall nanowire shift register. Science (2008) 2.68
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol (2003) 2.50
Dependence of current and field driven depinning of domain walls on their structure and chirality in permalloy nanowires. Phys Rev Lett (2006) 2.11
A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes. Pharmacoepidemiol Drug Saf (2007) 2.10
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol (2007) 2.00
NALP inflammasomes: a central role in innate immunity. Semin Immunopathol (2007) 1.91
Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol (2008) 1.53
Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. Development (2004) 1.53
Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol (2008) 1.51
Sarcoidosis and melanoma: a referral center study of 1,199 cases. Dermatology (2009) 1.49
The furrow ink test: a clue for the dermoscopic diagnosis of acral melanoma vs nevus. Arch Dermatol (2008) 1.44
Exclusively benign dermoscopic pattern in a patient with acral melanoma. Arch Dermatol (2007) 1.40
mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res (2005) 1.35
Frequency of dermoscopic nevus subtypes by age and body site: a cross-sectional study. Arch Dermatol (2011) 1.34
The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line. EMBO Rep (2009) 1.34
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer (2010) 1.25
Fusarium infections of the skin. Curr Opin Infect Dis (2000) 1.23
Dermoscopic Features of Onychomatricoma: A Study of 34 Cases. Dermatology (2015) 1.23
Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia. Am J Hum Genet (2007) 1.20
Onychomatricoma: new clinical and histological features. A review of 19 tumors. Am J Dermatopathol (2010) 1.20
Non-dermatophyte onychomycosis. Dermatol Clin (2003) 1.16
Enhanced stochasticity of domain wall motion in magnetic racetracks due to dynamic pinning. Nat Commun (2010) 1.15
Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol (2011) 1.15
Current driven domain wall velocities exceeding the spin angular momentum transfer rate in permalloy nanowires. Phys Rev Lett (2007) 1.15
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet (2011) 1.14
Vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 1.14
Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol (2008) 1.08
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. Melanoma Res (2014) 1.08
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients. Clin Cancer Res (2010) 1.07
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet (2013) 1.04
Subungual blue nevus. J Am Acad Dermatol (2003) 1.04
Beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A (2002) 1.01
Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol (2014) 0.99
Dermoscopic evaluation of nodular melanoma. JAMA Dermatol (2013) 0.99
Transverse melanonychia secondary to total skin electron beam therapy: a report of 3 cases. J Am Acad Dermatol (2005) 0.99
Bcl10 controls TCR- and FcgammaR-induced actin polymerization. J Immunol (2007) 0.98
Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol (2011) 0.97
Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia. Am J Med Genet A (2009) 0.96
Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains. J Biol Chem (2009) 0.92
Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrix. J Am Acad Dermatol (2006) 0.92
TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J Invest Dermatol (2012) 0.91
Targeted therapies in metastatic melanoma: toward a clinical breakthrough? Anticancer Agents Med Chem (2010) 0.90
Perineurioma of the nail on sonography. J Ultrasound Med (2010) 0.89
Onychomatricoma with dorsal pterygium: pathogenic mechanisms in 3 cases. J Am Acad Dermatol (2008) 0.89
Benign dermoscopic parallel ridge pattern variants. Arch Dermatol (2011) 0.89
TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis. Apoptosis (2013) 0.89
Discrete domain wall positioning due to pinning in current driven motion along nanowires. Nano Lett (2010) 0.89
Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome. J Drugs Dermatol (2009) 0.89
Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. Dermatology (2005) 0.89
Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules. PLoS One (2012) 0.88
Histological features and treatment approach of trichoblastic carcinomas: from a case report to a review of the literature. Tumori (2012) 0.88
Dermoscopy of Merkel cell carcinoma. Dermatology (2012) 0.88
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. Genes Chromosomes Cancer (2007) 0.88
Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies. J Biol Chem (2011) 0.88
Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra. Dermatology (2014) 0.88
Linear atrophoderma of moulin: report of 4 cases and 20th anniversary case review. Dermatology (2013) 0.87
Cooperative effects between protein kinase A and p44/p42 mitogen-activated protein kinase to promote cAMP-responsive element binding protein activation after beta cell stimulation by glucose and its alteration due to glucotoxicity. Ann N Y Acad Sci (2004) 0.87
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp. Am J Surg Pathol (2016) 0.86
Multiple adult xanthogranuloma: case report and literature review. Dermatology (2006) 0.86
The onychomatricoma: additional histologic criteria and immunohistochemical study. Am J Dermatopathol (2002) 0.86
Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol (2008) 0.85
Clinical and dermoscopic characteristics of desmoplastic melanomas. JAMA Dermatol (2013) 0.85
Dermoscopy of lymphomatoid papulosis. Arch Dermatol (2009) 0.85
Prognostic factors of paraneoplastic pemphigus. Arch Dermatol (2012) 0.85
The histopathological feature of the nail isthmus in an ectopic nail. Am J Dermatopathol (2011) 0.85
Using mathematical modeling in training planning. Int J Sports Physiol Perform (2006) 0.85
The induction of apoptosis by local anesthetics: a comparison between lidocaine and ropivacaine. Anesth Analg (2003) 0.84
Death receptors and apoptosis. Dermatol Clin (2007) 0.83
A clinico-dermoscopic approach for skin cancer screening: recommendations involving a survey of the International Dermoscopy Society. Dermatol Clin (2013) 0.83
US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens (Greenwich) (2010) 0.83
Skin cancers arising in tattoos: coincidental or not? Dermatology (2008) 0.83
Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy. Manag Care Interface (2002) 0.83
Fungal melanonychia. J Am Acad Dermatol (2012) 0.83
Tracking of second primary melanomas in vemurafenib-treated patients. JAMA Dermatol (2013) 0.83
Highly efficient in-line magnetic domain wall injector. Nano Lett (2015) 0.83
Halo nevus, rather than vitiligo, is a typical dermatologic finding of turner's syndrome: clinical, genetic, and immunogenetic study in 72 patients. J Am Acad Dermatol (2004) 0.82
Retronychia: proximal ingrowing of the nail plate. J Am Acad Dermatol (2008) 0.82
Localized longitudinal erythronychia: diagnostic significance and physical explanation. Arch Dermatol (2004) 0.82
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family. J Am Acad Dermatol (2012) 0.82
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer (2008) 0.81
New therapeutical strategies in the treatment of metastatic disease. Dermatol Ther (2012) 0.81
Ungueotropic T-cell lymphoma. Arch Dermatol (2006) 0.80